StockData
Envoy Medical, Inc. logo

Envoy Medical, Inc. (COCH) stock

COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$6.81−0.14 (-2.01%)

Close on Nov 12, 2026Market cap $525.69MP/E –Yield –

Envoy Medical, Inc. grew revenue 11.1% to $231.00K over the twelve months to Sep 30, 2026. Free cash flow was -$18.38M. At the latest close the market valued the company at $525.69M.

Revenue
$231.00K
+11.1% vs. a year earlier
Operating income
-$23.89M
TTM Q3 2026
Free cash flow
-$18.38M
FY2025
EPS, diluted
-$4.72
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$525.69M
P/E ratio
–
Price to sales
2275.74
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$231.00K
Net income
-$20.85M
EPS, diluted
-$4.72
Free cash flow
-$18.38M
Book value per share
-$0.15
Diluted shares
10M

Trading

Next earnings
Mar 26, 2027 (estimated, after the close)
Previous close
$6.95
Open
$6.86
Day's range
$6.80 – $6.92
Volume
12,916
Average volume (20 days)
41,156
Beta (5 years)
-0.40
52-week range
$0.43 – $9.54
RSI (14 days)
55.6
Volatility (1 year)
6024.3%
Relative volume
0.75×
WACC
7.4%

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodCOCHS&P 500DifferenceCOCH per yearS&P 500 per year
1 month+4.5%-2.7%+7.2 pts
3 months+813.7%-1.7%+815.5 pts
Year to date+3.0%+11.9%−8.9 pts
1 year-6.6%+12.0%−18.6 pts
3 years-27.6%+78.2%−105.7 pts-10.2%+21.2%
5 years-93.0%+73.2%−166.2 pts-41.2%+11.6%

Six years at a glance

Fiscal years 2020 to 2025 and trailing twelve months, USD

Revenue

$231.00K+11.1% YoY

Gross profit

-$815.00K

Operating income

-$23.89M

Net income

-$20.85M

EPS, diluted

-$4.72

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Envoy Medical filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Envoy Medical

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envoy Medical, Inc. is a hearing health medical device company that develops implantable hearing technologies designed to utilize the natural anatomy of the ear. The company focuses on developing electrical and mechanical hearing systems across the hearing loss spectrum. Its key product development includes the Acclaim cochlear implant, a fully implanted investigational system featuring an implanted sensor, sound processor, and power source that captures sound without external, ear-worn components. The company also developed the Esteem fully implanted active middle ear implant. Its devices are designed for adult patients suffering from hearing loss, specifically targeting individuals with severe-to-profound sensorineural hearing loss who obtain limited benefit from conventional hearing aids.

Company profile, executives and history

Envoy Medical stock: common questions

What is Envoy Medical's stock price?

COCH closed at $6.81 on Nov 12, 2026, down 2.01% on the day. Over the past 52 weeks it traded between $0.43 and $9.54.

What is Envoy Medical's market cap?

Envoy Medical was worth $525.69M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is COCH's P/E ratio?

Envoy Medical lost money over the twelve months to Sep 30, 2026 (diluted EPS -$4.72), so it has no meaningful P/E ratio.

How much revenue does Envoy Medical make?

Envoy Medical reported revenue of $231.00K for the twelve months to Sep 30, 2026, up 11.1% from a year earlier.

Does Envoy Medical pay a dividend?

No. Envoy Medical has not paid a cash dividend over the last twelve months.

When does Envoy Medical report earnings next?

Envoy Medical is expected to report Q4 FY2026 results on Mar 26, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has COCH stock performed over the past year?

Including dividends, COCH returned -6.6% over the past year, against +12.0% for the S&P 500.

Who are Envoy Medical's competitors?

Companies most similar to Envoy Medical by business, industry and size include FEED, QTEX, NXL, AVR, GUTS.

See a number that looks wrong?